×

Ariad CEO: Expanding Iclusig

1:47 PM ET Tue, 13 Jan 2015

Ariad CEO Harvey Berger, tells CNBC's Meg Tirrell commercially the company had a good year and provides insight into its new cancer drug, Iclusig.